Cargando…
Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease that causes high rates of disability and mortality worldwide because of severe progressive and irreversible symptoms. During the period of COPD initiation and progression, the immune system triggers the activation of vari...
Autores principales: | Liu, Meiling, Wu, Kang, Lin, Jinduan, Xie, Qingqiang, Liu, Yuan, Huang, Yin, Zeng, Jun, Yang, Zhaogang, Wang, Yifan, Dong, Shiyan, Deng, Weiye, Yang, Mingming, Wu, Song, Jiang, Wen, Li, Xuefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294190/ https://www.ncbi.nlm.nih.gov/pubmed/34305606 http://dx.doi.org/10.3389/fphar.2021.695957 |
Ejemplares similares
-
Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy
por: Gong, Ping, et al.
Publicado: (2020) -
Isoforskolin Alleviates AECOPD by Improving Pulmonary Function and Attenuating Inflammation Which Involves Downregulation of Th17/IL-17A and NF-κB/NLRP3
por: Xiao, Chuang, et al.
Publicado: (2021) -
Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?
por: Li, Xuefeng, et al.
Publicado: (2022) -
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
por: Xie, Jing, et al.
Publicado: (2020) -
IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
por: Deng, Zhenzhen, et al.
Publicado: (2023)